Paxman Coolers Ltd.

Keeping it cool across the globe

scalp cooling
Losing hair during chemotherapy is a devastating effect of cancer treatment and serves as a constant reminder to the life threatening disease, but Paxman Ltd’s cooling systems reduce the risk of hair loss; improving patient’s self confidence and enabling them to retain their dignity.

Paxman Ltd’s next generation hair loss prevention systems – Orbis I & II - aim to minimise patient distress with figures showing that on average 70-90% of patients who use the system do not require a wig.

The company will be at MEDICA this month – the largest healthcare trade show in the world – offering their self esteem raising solutions to a worldwide audience.
Cooling the scalp during chemotherapy means that less of the chemotherapy drug reaches the hair follicles so the hair is less likely to fall out; reducing distress for the patient at an already traumatic time and enabling them to have the confidence to live an unrestricted life.
Former patient, Debbie Wolfe, said: “My illness would have been 100% more difficult for me if I had not used the system. I wouldn't have felt confident enough to go out as much and my life would have taken longer to get back to normal.”

Made from lightweight, silicone tubing, the scalp cooling cap itself is soft and flexible - providing a snug yet comfortable cap during treatment.

Moulding to all head shapes and sizes, liquid coolant passes through the cap extracting heat from the patient's scalp, ensuring the scalp remains at an even, constant temperature; minimising hair loss.

The caps are worn 30 minutes before the start of chemotherapy, during the treatment itself and for a period of time after infusion of the chemotherapy depending on the toxicity of the drugs.

With straightforward programming and controls, including recommended cooling time guides, the new compact system is uncomplicated and easy to understand for both medical staff and patients.

The Paxman system is available in two models. Orbis I provides cooling for a single patient and is suitable for a small chemotherapy suite or private bed, whilst the Orbis II provides cooling for one or two patients simultaneously with each cap working independently.

The systems are used all over the world and Paxman are travelling to Medica this month to speak to current and potential distributors across the globe.

Richard Paxman, Operations Director, said: “Preserving self esteem during chemotherapy leads to a more positive attitude to treatment and gives patients a rare light in a dark time of their lives. We’re passionate about providing help to patients around the world and hope Medica will allow us to offer the solution to thousands more patient’s worldwide.”

To meet with Paxman Coolers at MEDICA or for further information on their products, please visit their website www.paxman-coolers.com or contact them at info@paxman-coolers.com

MEDICA is the largest medical technologies fair in the world and will be taking place between 17-20th November at the Messe Düsseldorf. Throughout the show Paxman will be located on the UK Pavilion, hall 16 stand G10.